Changes of Serum Concentrations of Alkaline Phosphatase and Metalloproteinase-9 in an Ovariectomized Wistar Rat Model of Osteoporosis

1. Szulc P, Mary LB. Overview of osteoporosis: Epidemiology and clinical management. Vertebral Fracture Initiative Resource Document PART I. International Osteoporosis Foundation; 2011.Search in Google Scholar

2. Senthilkumar K, Venkatesan J, Kim S. Marine derived natural products for osteoporosis. Biomed Prev Nutr. 2014;4(1):1-7.10.1016/j.bionut.2013.12.005Search in Google Scholar

3. Turner R, Riggs B, Spelsberg T. Skeletal effects of estrogen. Endocr Rev. 1994;15(3):275-300.Search in Google Scholar

4. Walsh JS, Eastell R. Role of estrogen in the age-related decline in bone microstructure. Clin Endocrinol Metab J. 2013;98(2):519-21.10.1210/jc.2013-104923390264Open DOISearch in Google Scholar

5. Löffek S, Schilling O, Franzke C. Biological role of matrix metalloproteinases: a critical balance. Eur Respir J. 2011;38(1):191-208.10.1183/09031936.0014651021177845Open DOISearch in Google Scholar

6. Faienza M, Ventura A, Marzano F, Cavallo L. Postmenopausal osteoporosis: the role of immune system cells. Clin Dev Immunol. 2013;2013:575936.10.1155/2013/575936367700823762093Search in Google Scholar

7. Nagase H, Woessner J. Matrix metalloproteinases. J Biol Chem. 1999;274(31):21491-4.10.1074/jbc.274.31.2149110419448Search in Google Scholar

8. Galliera E, Banfi G, Corsi M. Human bone disorders: pathological role and diagnostic potential of matrix metalloproteinases. Int J Biochem Cell Biol. 2010;42(10):1590-3.10.1016/j.biocel.2010.06.01520601084Search in Google Scholar

9. Sbardella D, Fasciglione G, Gioia M, Ciaccio C, Tundo G, Marini S, et al. Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. Mol Aspects Med. 2012;33(2):119-208.10.1016/j.mam.2011.10.01522100792Open DOISearch in Google Scholar

10. Sun B, Sun J, Han X, Liu H, Li J, Du J, et al. Immunolocalization of MMP 2, 9 and 13 in prednisolone induced osteoporosis in mice. Histol Histopathol. 2016;31(6):647-56.Search in Google Scholar

11. Krane S, Inada M. Matrix metalloproteinases and bone. Bone. 2008;43(1):7-18.10.1016/j.bone.2008.03.02018486584Open DOISearch in Google Scholar

12. Bord S, Horner A, Hembry RM, Reynolds JJ, Compston JE. Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone. J Anat. 1997;191(1):39-48.10.1046/j.1469-7580.1997.19110039.x14676579279657Search in Google Scholar

13. Kharode YP, Sharp MC, Bodine PV. Utility of the ovariectomized rat as a model for human osteoporosis in drug discovery. Methods Mol Biol. 2008;455:111-24.10.1007/978-1-59745-104-8_818463814Search in Google Scholar

14. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006;116(5):1186-94. doi:10.1172/JCI28550.10.1172/JCI28550145121816670759Search in Google Scholar

15. Zhao H, Cai G, Du J, Xia Z, Wang L, Zhu T. Expression of matrix metalloproteinase-9 mRNA in osteoporotic bone tissues. J Tongji Med Univ. 1997;17(1):28-31.10.1007/BF028879989639781Search in Google Scholar

16. Logar DB, Komadina R, Prezelj J, Ostanek B, Trost Z, Marc J. Expression of bone resorption genes in osteoarthritis and in osteoporosis. J Bone Miner Metab. 2007;25(4):219-25.10.1007/s00774-007-0753-017593491Open DOISearch in Google Scholar

17. Kim SK, Lee MH, Rhee MH. Studies on the effects of biomedicinal agents on serum concentration of Ca²⁺, P and ALP activity in osteoporosis-induced rats. J Vet Sci. 2003;4(2):151-4.10.4142/jvs.2003.4.2.151Search in Google Scholar

18. Parikh P, Suresh B, Rangrez A. Osteoprotective effect of Litsea glutinosa in ovariectomized wistar rats. Electronic Journal of Pharmacology and Therapy. 2009;2:81-6.Search in Google Scholar

19. Brodowski J. [Levels of ionized magnesium in women with various stages of postmenopausal osteoporosis progression evaluated on the basis of densitometric examinations]. Przeglad lekarski. 1999;57(12):714-6. Polish.Search in Google Scholar

20. Castiglioni S, Cazzaniga A, Albisetti W, Maier JAM. Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients. 2013;5(8):3022-33.10.3390/nu5083022377524023912329Search in Google Scholar

21. Riggs B, Khosla S, Melton L. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res. 1998;13(5):763-73.10.1359/jbmr.1998.13.5.7639610739Search in Google Scholar

22. Andrusishina I. Diagnostic values of calcium and magnesium forms determined in human serum and saliva. J Elementol. 2010;15(3):425-33.Search in Google Scholar

23. Alam MR, Kim SM, Lee JI, Chon SK, Choi SJ, Choi IH, et al. Effects of Safflower seed oil in osteoporosis induced-ovariectomized rats. Am J Chin Med. 2006;34(4):601-12.10.1142/S0192415X0600413216883631Search in Google Scholar

24. Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam MR. Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology. 2000;141(11):4295-308.10.1210/endo.141.11.776511089565Search in Google Scholar

25. Lizcano F, Guillermo G. Estrogen deficiency and the origin of obesity during menopause. Biomed Res Int [Internet]. 2014 [cited 2017 Jun 19];2014:757461[about 11 p.]. Available from:. http://dx.doi.org/10.1155/2014/757461.10.1155/2014/757461396473924734243Search in Google Scholar